Cargando…
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
Throughout the last decades, dendritic cell (DC)-based anti-tumor vaccines have proven to be a safe therapeutic approach, although with inconsistent clinical results. The functional limitations of ex vivo monocyte-derived dendritic cells (MoDCs) commonly used in these therapies are one of the pointe...
Autores principales: | Calmeiro, João, Carrascal, Mylène A., Tavares, Adriana Ramos, Ferreira, Daniel Alexandre, Gomes, Célia, Falcão, Amílcar, Cruz, Maria Teresa, Neves, Bruno Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076373/ https://www.ncbi.nlm.nih.gov/pubmed/32075343 http://dx.doi.org/10.3390/pharmaceutics12020158 |
Ejemplares similares
-
Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy
por: Calmeiro, João, et al.
Publicado: (2019) -
In-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapy
por: Calmeiro, João, et al.
Publicado: (2021) -
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
por: Amon, Lukas, et al.
Publicado: (2020) -
Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020) -
Dendritic cell immunotherapy: clinical outcomes
por: Apostolopoulos, Vasso, et al.
Publicado: (2014)